BioHarvest Sciences Inc.
BHST | NASDAQ
$1.51
-$0.11 (-6.79%)
At close: Sep 22, 2026, 4:00 PM ET
$1.51
$0 (0.00%)
After-hours:
Sep 22, 2026, 7:46 PM ET
-6.79%
(1D)Rating
Updated: Aug 27, 2026Key Statistics
Market Data
Market Cap $26.16M
1D Range
1.51 1.65
52W Range
1.51 12.80
Valuation (TTM)
PE -3
PB 1.42
EV/EBITDA -4.03
Valuation (NTM)
Forward PE 34.20
Forward PEG 0.08
Price Target $5
Cash Flow
FCF Yield -39.0%
SBC Adj. FCF Yield -39.5%
SBC Impact -1.4%
Margins
Gross Margin 59.0%
Operating Margin -18.0%
FCF Margin -30.9%
Growth (CAGR)
Revenue 3Y | 5Y 58.7% |
102.5%
Dil EPS 3Y | 5Y 40.1% |
6.4%
FCF 3Y | 5Y -9.5% |
-2.1%
Returns
ROA -24.8%
ROE -58.3%
ROIC -17.1%
Financial Health
Net Cash
$528K
Current Ratio 2.24
Interest Coverage -1.21
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
BioHarvest Sciences Inc. is a biotechnology company that operates through two segments: Products and CDMO Services. The company has developed a botanical synthesis platform technology to grow plant ce...
Sector Industrials
Industry Agricultural - Commodities/Milling
Employees 89
IPO Date Jan 7, 2021
Website www.bioharvest.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$5
Upside
+231.13%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove BHST